Why genomics needs digital health to succeed
Genomics is at a critical inflection point in healthcare, visible through its growing presence in ongoing debates surrounding personal health data and its centrality to precision medicine initiatives around the globe.
Delivering on the promise of genomics depends on three main factors—many of which are within the purview of digital health. We wanted to add some more data to the conversation; we’re excited to announce results from our survey of one thousand consumers and our latest report, The Genomics Inflection Point: Implications for Healthcare.
Note: Only includes US deals >$2M. For the purposes of this report, we did not include basic life sciences tools, synthetic DNA, or gene editing companies
Headlines
The Genomics Inflection Point: Implications For Healthcare
Tweet | Rock Health
Stop The Privatization Of Health Data
Tweet | Nature
US Sues To Block Anthem-Cigna And Aetna-Humana Mergers
Tweet | The New York Times
Despite Pushback From Congress, CMS Readies Star-Based Hospital Ratings
Tweet | MedCity News
Information Blocking Allegations Surface In CMS Emails
Tweet | Politico
ONC To Congress: Protect Patient Health Data That Falls Outside HIPAA
Tweet | MobiHealthNews
Microhospitals Filling Some ER Needs
Tweet | Kaiser Health News
Funding
| Company | Amt | Investors | Source |
| Azalea Health | $10.5M | Kayne Partners, Intersmith Partners | MobiHealthNews |
Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.